Works matching AU Garrison Jr., Louis P.

Results: 31

Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study.

Published in:

2019

By:

Guzauskas, Gregory F.;
Pollom, Erqi L.;
Stieber, Volker W.;
Wang, Bruce C.M.;
Garrison Jr, Louis P.;
Garrison, Louis P Jr

Publication type:

journal article

A framework for assessing the economic value of pharmacovigilance in low- and middle-income countries.

Published in:

2014

By:

Babigumira, Joseph B;
Stergachis, Andy;
Choi, Hye Lyn;
Dodoo, Alexander;
Nwokike, Jude;
Garrison Jr, Louis P;
Garrison, Louis P Jr

Publication type:

journal article

Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication Program.

Published in:

Journal of Infectious Diseases, 2011, v. 204, p. S116, doi. 10.1093/infdis/jir132

By:

Babigumira, Joseph B.;
Levin, Ann;
Burgess, Colleen;
Garrison Jr., Louis P.;
Bauch, Chris T.;
Braka, Fiona;
Mbabazi, William B.;
Nabyonga, Juliet O.;
Simons, Emily;
Dabbagh, Alya

Publication type:

Article

Using Cost-Effectiveness Analysis to Support Research and Development Portfolio Prioritization for Product Innovations in Measles Vaccination.

Published in:

Journal of Infectious Diseases, 2011, v. 204, p. S124, doi. 10.1093/infdis/jir114

By:

Garrison Jr., Louis P.;
Bauch, Chris T.;
Bresnahan, Brian W.;
Hazlet, Tom K.;
Kadiyala, Srikanth;
Veenstra, David L.

Publication type:

Article

Global Eradication of Measles: An Epidemiologic and Economic Evaluation.

Published in:

Journal of Infectious Diseases, 2011, v. 204, p. S98, doi. 10.1093/infdis/jir096

By:

Levin, Ann;
Burgess, Colleen;
Garrison Jr., Louis P.;
Bauch, Chris;
Babigumira, Joseph;
Simons, Emily;
Dabbagh, Alya

Publication type:

Article

An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases.

Published in:

Advances in Therapy, 2025, v. 42, n. 2, p. 568, doi. 10.1007/s12325-024-03076-5

By:

Yang, Min;
Mittal, Manish;
Fendrick, A. Mark;
Brixner, Diana;
Sherman, Bruce W.;
Liu, Yifei;
Patel, Pankaj;
Clewell, Jerry;
Liu, Qing;
Garrison Jr., Louis P.

Publication type:

Article

Rewarding Value Creation to Promote Innovation in Oncology: The Importance of Considering the Global Product Life Cycle.

Published in:

Oncologist, 2010, v. 15, p. 49, doi. 10.1634/theoncologist.2010-S1-49

By:

Garrison, Jr., Louis P.

Publication type:

Article

Assessment of the Effectiveness of Supply-Side Cost-Containment Measures.

Published in:

Health Care Financing Review, 1991, v. 13, n. 2, p. 13

By:

Garrison Jr., Louis P.

Publication type:

Article

Assessment of the effectiveness of supply-side cost-containment measures.

Published in:

Health Care Financing Review, 1991, v. 12, p. 13

By:

Garrison Jr., Louis P.

Publication type:

Article

Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics.

Published in:

Journal of Personalized Medicine, 2017, v. 7, n. 3, p. 10, doi. 10.3390/jpm7030010

By:

Garrison Jr., Louis P.;
Towse, Adrian

Publication type:

Article

The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer.

Published in:

2021

By:

Jiao, Boshen;
Garrison, Louis P.;
Garrison, Louis;
Garrison, Louis P , Jr

Publication type:

journal article

Is the price right? Paying for value today to get more value tomorrow.

Published in:

BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03262-w

By:

Ramagopalan, Sreeram V.;
Diaz, Jose;
Mitchell, Grace;
Garrison Jr., Louis P.;
Kolchinsky, Peter

Publication type:

Article

Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A.

Published in:

2020

By:

Cook, Keziah;
Forbes, Shaun P.;
Adamski, Kelly;
Ma, Janice J.;
Chawla, Anita;
Garrison, Louis P.;
Garrison, Louis P Jr

Publication type:

journal article

Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis.

Published in:

2018

By:

Zimmermann, Marita;
Vodicka, Elisabeth;
Holman, Andrew;
Garrison, Louis P Jr.;
Holman, Andrew J

Publication type:

journal article

Cost and Health Care Utilization Implications of Bariatric Surgery Versus Intensive Lifestyle and Medical Intervention for Type 2 Diabetes.

Published in:

2017

By:

Banerjee, Souvik;
Garrison, Louis P.;
Flum, David R.;
Arterburn, David E.;
Garrison, Louis P Jr

Publication type:

journal article

Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of "Failed" R&D Efforts.

Published in:

International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000150

By:

Xie, Richard Z.;
Towse, Adrian;
Garrison Jr., Louis P.

Publication type:

Article

Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer's Disease in the United States.

Published in:

Neurology & Therapy, 2024, v. 13, n. 6, p. 1641, doi. 10.1007/s40120-024-00649-y

By:

Boustani, Malaz;
Doty, Erin G.;
Garrison Jr, Louis P.;
Smolen, Lee J.;
Klein, Timothy M.;
Murphy, Daniel R.;
Spargo, Andrew W.;
Belger, Mark;
Johnston, Joseph A.

Publication type:

Article

Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting.

Published in:

2011

By:

Bergenstal, Richard M;
Garrison Jr, Louis P;
Wintle, Matthew;
Blickensderfer, Amy;
Wade, Rolin;
Hou, Likun;
Miller, Lesley-Ann;
Scism-Bacon, Jamie;
Zagar, Anthony;
Misurski, Derek;
Herman, William H

Publication type:

Journal Article

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.

Published in:

2016

By:

Mann, Marita;
Mengistu, Assegid;
Gaeseb, Johannes;
Sagwa, Evans;
Mazibuko, Greatjoy;
Babigumira, Joseph;
Garrison, Louis;
Stergachis, Andy;
Babigumira, Joseph B;
Garrison, Louis P Jr

Publication type:

journal article

Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing.

Published in:

Public Health Genomics, 2011, v. 14, n. 2, p. 59, doi. 10.1159/000290452

By:

Roth, Joshua A.;
Garrison Jr., Louis P.;
Burke, Wylie;
Ramsey, Scott D.;
Carlson, Rick;
Veenstra, David L.

Publication type:

Article

Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.

Published in:

2006

By:

Sander, Beate;
Hayden, Frederick G.;
Gyldmark, Marlene;
Garrison, Louis P.;
Garrison, Louis P Jr

Publication type:

journal article

Employment and health benefits: A connection at risk.

Published in:

1994

By:

Garrison Jr., Louis P.

Publication type:

Book Review

Modeling the ExAnte Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer.

Published in:

PharmacoEconomics, 2022, v. 40, n. 6, p. 623, doi. 10.1007/s40273-022-01147-5

By:

Lee, Woojung;
Wong, William B.;
Kowal, Stacey;
Garrison Jr., Louis P.;
Veenstra, David L.;
Li, Meng

Publication type:

Article

Performance-Based Risk-Sharing Arrangements: An Updated International Review.

Published in:

2017

By:

Carlson, Josh;
Chen, Shuxian;
Garrison, Louis;
Carlson, Josh J;
Garrison, Louis P Jr

Publication type:

journal article

Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research.

Published in:

PharmacoEconomics, 2010, v. 28, n. 10, p. 855, doi. 10.2165/11538640-000000000-00000

By:

Garrison, Jr., Louis P.

Publication type:

Article

Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.

Published in:

2010

By:

Towse A;
Garrison LP Jr;
Towse, Adrian;
Garrison, Louis P Jr

Publication type:

journal article

Can't Get No Satisfaction? Will Pay for Performance Help?

Published in:

PharmacoEconomics, 2010, v. 28, n. 2, p. 93, doi. 10.2165/11314080-000000000-00000

By:

Towse, Adrian;
Garrison Jr., Louis P.

Publication type:

Article

Cost-Effectiveness Analysis of Trastuzumab in the Adjuvant Setting for Treatment of HER2-Positive Breast Cancer.

Published in:

Cancer (0008543X), 2007, v. 110, n. 3, p. 489, doi. 10.1002/cncr.22806

By:

Garrison Jr., Louis P.;
Lubeck, Deborah;
Lalla, Deepa;
Paton, Virginia;
Dueck, Amylou;
Perez, Edith A.

Publication type:

Article

New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement.

Published in:

Vaccines, 2024, v. 12, n. 3, p. 234, doi. 10.3390/vaccines12030234

By:

Buck, Philip O.;
Gomes, Dumingu Aparna;
Beck, Ekkehard;
Kirson, Noam;
Mattera, Matthew;
Carroll, Stuart;
Ultsch, Bernhard;
Jayasundara, Kavisha;
Uhart, Mathieu;
Garrison, Jr., Louis P.

Publication type:

Article

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States.

Published in:

Vaccines, 2017, v. 5, n. 2, p. 13, doi. 10.3390/vaccines5020013

By:

Adamson, Blythe J. S.;
Carlson, Josh J.;
Kublin, James G.;
Garrison Jr., Louis P.

Publication type:

Article

A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone app.

Published in:

PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0316001

By:

Asirwa, Fredrick Chite;
Bresnahan, Brian W.;
Yego, Faith;
Duncan, Dana;
Karichu, James K.;
Garrison Jr., Louis P.

Publication type:

Article